NEW YORK (GenomeWeb News) - Less than two years after unveiling its initial offering of instruments, Invitrogen CEO Greg Lucier told investors during the firm’s first-quarter conference call last month that the development of small instrument systems would continue to be a focused part of Invitrogen’s growth strategy and that a transplant diagnostics system would soon hit the market.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In its survey of US adults, the Pew Research Center finds that views on the genetic engineering of animals depend on why it's done.

York University researchers find genomic evidence of inbreeding in the yellow-banded bumblebee, according to Reuters.

The Scientist reports agricultural researchers are working on a gene-stacking tool.

In Nature this week: statistical method for overcoming case-control imbalance issues, and more.